The earnings call highlighted successful capital restructuring and cost reductions, along with growth in wholesale revenue and an award-winning product launch. However, challenges include a decrease in total net sales, flat e-commerce revenue, and a negative working capital position.

Company Guidance

In the recent cbdMD, Inc. conference call discussing fiscal year 2025 second-quarter results, the company provided several key metrics and strategic updates. The company's revenue for the second quarter was $4.7 million, marking an 8.6% increase from the previous year's comparable quarter, although it represented a 7.9% decrease from the first quarter of fiscal 2025. The direct-to-consumer e-commerce sales accounted for $3.6 million, or 77% of total net sales, while wholesale business revenue was up by 22% year-over-year, reaching $1.1 million. The company's gross profit margin remained strong at 62%, despite increased warehouse rent and CAM costs. Operating losses were reduced to approximately $485,000 from $1.5 million in the previous year. The non-GAAP adjusted EBITDA loss was $197,000, a marked improvement from a $680,000 loss in the prior year. The company reported cash and cash equivalents of about $1.7 million, with a working capital deficit of $3.7 million. The strategic focus on restructuring has led to a significant improvement in the capital structure, with the conversion of Series A Preferred Stock into common stock, raising the book value to over $7 million and eliminating $4 million in annual dividends. The company also highlighted its growth initiatives, including the expansion of its Herbal Oasis THC seltzer brand and a commitment to profitability by year-end, alongside exploring strategic opportunities through potential mergers and acquisitions.

Successful Capital Restructuring

The conversion of Series A preferred stock into common stock was successfully completed, eliminating $6.7 million in accrued dividends and simplifying the capital structure. This raised the pro forma non-GAAP adjusted book value from approximately $670,000 to over $7 million.

Wholesale Revenue Growth

Wholesale revenue increased by 22% in the second quarter of fiscal 2025 compared to the same period in 2024, reaching $1.1 million.

Cost Reductions

SG&A expenses for Q2 2025 were reduced to $3.5 million from $4.1 million in the prior year, primarily due to reductions in payroll, professional fees, and the elimination of the headquarters lease.

Improvement in Non-GAAP Adjusted EBITDA

The non-GAAP adjusted EBITDA loss improved to $197,000 for Q2 2025 compared to a $680,000 loss in Q2 2024.

Award-Winning Herbal Oasis Brand

Herbal Oasis, a hemp-derived THC seltzer brand, received awards at the 2025 High Spirits Award and expanded distribution in several states.

cbdMD (YCBD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

YCBD Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Dec 23, 2025	2025 (Q4)	-0.07 / -	0	―	―	―
Aug 14, 2025	2025 (Q3)	-0.02 / -0.21	-1.2	82.50% (+0.99)	―
May 15, 2025	2025 (Q2)	-1.60 / -1.90	-10.8	82.41% (+8.90)	―
Feb 13, 2025	2025 (Q1)	- / -1.76	-5.36	67.16% (+3.60)	―	―
Dec 18, 2024	2024 (Q4)	-3.60 / 0.00	-46.96	―	―	―
Aug 14, 2024	2024 (Q3)	-4.96 / -1.20	-9.28	87.07% (+8.08)	―	―
May 15, 2024	2024 (Q2)	-6.00 / -10.80	-13.92	22.41% (+3.12)	―	―
Feb 13, 2024	2024 (Q1)	-5.92 / -5.36	-28.8	81.39% (+23.44)	―
Dec 22, 2023	2023 (Q4)	-6.08 / -46.96	-11.595	-305.00% (-35.37)	―
Aug 10, 2023	2023 (Q3)	- / -9.28	-24.758	62.52% (+15.48)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

YCBD Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 14, 2025	$0.85	$0.76	-10.59%
May 15, 2025	$0.99	$0.95	-4.04%
Feb 13, 2025	$4.56	$3.87	-15.13%
Dec 18, 2024	$3.18	$2.96	-6.92%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does cbdMD (YCBD) report earnings?

cbdMD (YCBD) is schdueled to report earning on Dec 23, 2025, Before Open (Confirmed).

What is cbdMD (YCBD) earnings time?

cbdMD (YCBD) earnings time is at Dec 23, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is YCBD EPS forecast?

YCBD EPS forecast for the fiscal quarter 2025 (Q4) is -0.07.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing